DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc. announced today the launch of its initial public offering of 7,150,000 shares of common stock (the “Offering”) pursuant to a registration statement filed on Form S-1 with the Securities and Exchange Commission. In addition, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 1,072,500 shares of its common stock. The estimated initial public offering price range is $13.00 to $15.00 per share. Arcadia has applied to list its common stock on The NASDAQ Global Market under the symbol “RKDA.”
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
